Skip to main content
Beximco Pharmaceuticals Ltd. logo

Beximco Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · BXP ISIN · US0885792061 LEI · 213800IMBBD6TIOQGB56 IL Manufacturing
Open in API
Filings indexed 125 across all filing types
Latest filing 2024-04-30 Interim / Quarterly Rep…
Country BD Bangladesh
Listing IL BXP

About Beximco Pharmaceuticals Ltd.

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd. is a manufacturer of generic drugs and active pharmaceutical ingredients (APIs). The company produces a broad portfolio of over 500 products across various therapeutic categories, with a focus on providing access to affordable medicines. It has established a strong market differentiation through a range of high-tech, specialized products, including metered-dose and dry powder inhalers. Serving numerous emerging and developed markets globally, its manufacturing facilities are accredited by major international regulatory authorities, including those of the USA, European Union, Australia, and Canada.

Recent filings

Filing Released Lang Actions
Q3 Financial Results
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the third quarter and nine months ended 31 March 2024. It includes detailed consolidated financial statements, such as the Statement of Financial Position, Statement of Profit or Loss, Statement of Changes in Equity, and Statement of Cash Flows. Since it contains substantive financial data and analysis for an interim period rather than just an announcement or a summary, it is classified as an Interim/Quarterly Report. 9M 2024
2024-04-30 English
Appointment of Managing Director
Board/Management Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals Limited regarding the appointment of a new Managing Director, Mr. Iqbal Ahmed. This falls directly under the category of board or management changes.
2024-03-04 English
Half Year Results 2023-24
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for Beximco Pharmaceuticals Ltd covering the six-month period ended 31 December 2023. It includes detailed unaudited financial statements, specifically the Consolidated Statement of Financial Position, Statement of Profit or Loss and Other Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows. Since it covers a period shorter than a full fiscal year and contains substantive financial data, it is classified as an Interim/Quarterly Report (IR). H1 2023
2024-01-30 English
Payment of Cash Dividend
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals regarding the payment of a cash dividend that was previously approved at their AGM. It provides specific details about the dividend amount, the payment date, and instructions for GDR holders. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2024-01-25 English
Board Change
Board/Management Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals Limited regarding the resignation of their Managing Director, Mr. Nazmul Hassan MP. The title explicitly states 'Board Change'. This fits the definition of a management/board change announcement, which is categorized under 'MANG'.
2024-01-11 English
AGM Statement
AGM Information Classification · 1% confidence The document is an RNS announcement from Beximco Pharmaceuticals Limited regarding the results of their Annual General Meeting (AGM). It confirms that all resolutions were passed, including the approval of a cash dividend. While it mentions the Annual Report, it is not the report itself, but rather a short announcement (under 5,000 characters) summarizing the meeting outcomes and voting results. Therefore, it is classified as a Declaration of Voting Results & Voting Rights Announcement (DVA).
2023-12-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.